Small Stocks, Big Money

RedChip Companies
  • 5.0 (1)
  • BUSINESS
  • UPDATED SEMIWEEKLY
Small Stocks, Big Money

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

  1. 2D AGO

    BullFrog AI CEO Vin Singh on Revolutionizing Drug Development with AI-Powered Insights

    BullFrog AI, a US-company headquartered in Maryland, is revolutionizing drug discovery and development with BullFrog Data Networks®, a cutting-edge platform powered by its proprietary bfLEAP® technology. Designed for small and mid-sized biopharma companies, BullFrog Data Networks® enables users to harness high-dimensional, multi-modal datasets, uncovering hidden relationships and pathways to accelerate target identification, clinical trial optimization, and drug repurposing. By providing affordable, AI-powered insights, BullFrog AI enhances decision-making and efficiency across the industry—helping resource-constrained organizations do more with less while enabling larger enterprises to optimize R&D investments and streamline drug development. In addition to driving growth through its Data Networks platform, BullFrog AI continues to advance its portfolio of licensed drug assets and partnerships with world-class research institutions like the J. Craig Venter Institute and the Lieber Institute for Brain Development.Bullfrog AI is a client of RedChip. Visit RedChip.com/stocks/BFRG to learn more.

    6 min

  2. APR 1

    LiveOne (Nasdaq: LVO) CEO Robert Ellin on Disrupting Music, Media & Monetization

    Headquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an award-winning, creator-first, music, entertainment, and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events. LiveOne's subsidiaries include Slacker Radio, PodcastOne (Nasdaq: PODC), PPVOne, CPS, LiveXLive, DayOne Music Publishing, Drumify and Splitmind. LiveOne is available on iOS, Android, Roku, Apple TV, Spotify, Samsung, Amazon Fire, Android TV, and through STIRR's OTT applications.LiveOne is a client of RedChip. Visit www.redchip.com/stocks/LVO to learn more.

    10 min

  3. MAR 25

    Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential

    Nexalin Technology is a pioneering medical technology company focused on addressing the global mental health crisis through innovative neurostimulation devices. Nexalin's products, which include the Gen-2 and newly introduced Gen-3 HALO™ Clarity devices, are non-invasive and utilize advanced frequency-based stimulation to target deep brain structures associated with various mental health disorders. These disorders include but are not limited to depression, anxiety, insomnia, PTSD, and traumatic brain injuries. Nexalin's commitment to non- pharmacological treatment options is underpinned by extensive clinical research and intellectual property protections, aiming to provide significant therapeutic benefits without adverse effects. The company's approach integrates product innovation with a virtual clinic model to enhance accessibility and effectiveness of treatments, offering a significant step forward in mental healthcare.Nexalin Technology is a client of RedChip. Visit RedChip.com to learn more.

    13 min

  4. MAR 18

    Inside Knightscope (Nasdaq: KSCP): CEO William Santana Li on AI, Robotics & Crime Prevention

    Knightscope (Nasdaq: KSCP) is transforming public safety with cutting-edge robotics and AI technologies. From autonomous security robots to advanced detection systems, Knightscope is committed to building safer communities where you live, work, study and visit. Their long-term ambition is bold but simple: to make the United States of America the safest country in the world.Knightscope is a client of RedChip Companies. Visit RedChip.com to learn more.

    13 min

  5. MAR 11

    Jupiter Neurosciences CEO Christer Rosén on Advancing Neuroinflammation Treatments & Beyond

    Jupiter Neurosciences, Inc. (Nasdaq: JUNS) is a clinical-stage pharmaceutical company pioneering treatments for neuroinflammation and rare diseases through its proprietary resveratrol delivery platform. Its lead product, JOTROL™, offers groundbreaking bioavailability—nine times greater than traditional resveratrol formulations—enabling safe, effective treatment for CNS disorders like Alzheimer's and Parkinson's. Backed by elite research partnerships and a robust clinical pipeline, including multiple Phase 2 trials expected to launch within the next 12 months, Jupiter is also advancing a near-term direct-to-consumer revenue opportunity in nutraceuticals, positioning the company as a transformative force in both pharmaceutical and consumer health markets.Jupiter Neurosciences is a client of RedChip. Visit www.redchip.com/stocks/JUNS to learn more.

    11 min

  6. MAR 4

    Alliance Entertainment: Inside The Billion-Dollar Giant Powering Media Distribution Globally

    Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailers. The company partners with nearly every major film studio, music label, and video game maker, including Disney, Sony, Universal, Warner Bros., Universal Music, Sony Music, Warner Music, Microsoft, and Nintendo, to distribute their products to retailers worldwide. With over 325,000 in stock SKUs, Alliance supplies major retailers like Walmart, Amazon, and Best Buy, as well as thousands of independent stores. In fiscal 2024, Alliance generated over $1.1 billion in revenue, with more than $250 million from exclusive distribution deals. As the dominant force in the physical media market, Alliance's unmatched scale and reach secure its leadership position. Looking ahead, the company remains committed to fueling its growth through strategic acquisitions, leveraging its proven ability to expand and strengthen its portfolio in an evolving industry.Alliance Entertainment is a client of RedChip. Visit RedChip.com to learn more.

    8 min

  7. FEB 25

    Inside Calidi Biotherapeutics: CFO Andrew Jackson Breaks Down the Future of Oncolytic Virotherapy

    Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Calidi’s preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California.Calidi Biotherapeutics is a client of RedChip. Visit www.redchip.com/stocks/cldi to learn more.

    6 min

  8. FEB 18

    60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoffrey Dow on Expanding Malaria Prevention & Beyond

    60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. 60P has successfully achieved regulatory approval of ARAKODA® (tafenoquine), a malaria preventative treatment that has been on the market since late 2019. Currently, 60P’s pipeline includes development programs for Tafenoquine and Celgosivir targeting fungal, tick-borne, and other viral diseases.60P is a client of RedChip. Visit www.redchip.com/stocks/sxtp to learn more.

    8 min
See All (87)

About

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

Information

  • Creator
    RedChip Companies
  • Years Active
    2023 - 2025
  • Episodes
    87
  • Rating
    Clean
  • Copyright
    © RedChip Companies
  • Show Website
    Small Stocks, Big Money

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada